Yu Seol Lee

744 total citations
14 papers, 459 citations indexed

About

Yu Seol Lee is a scholar working on Epidemiology, Molecular Biology and Oncology. According to data from OpenAlex, Yu Seol Lee has authored 14 papers receiving a total of 459 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 9 papers in Molecular Biology and 2 papers in Oncology. Recurrent topics in Yu Seol Lee's work include Liver Disease Diagnosis and Treatment (7 papers), Genomics, phytochemicals, and oxidative stress (6 papers) and Autophagy in Disease and Therapy (5 papers). Yu Seol Lee is often cited by papers focused on Liver Disease Diagnosis and Treatment (7 papers), Genomics, phytochemicals, and oxidative stress (6 papers) and Autophagy in Disease and Therapy (5 papers). Yu Seol Lee collaborates with scholars based in South Korea and United States. Yu Seol Lee's co-authors include Soo Han Bae, Da Hyun Lee, Jeong Su Park, Yong‐ho Lee, Dong‐Kyu Lee, Sung Won Kwon, Dai Hoon Han, Su Haeng Sung, Myung‐Shik Lee and Jinyoung Kim and has published in prestigious journals such as Nature Communications, Hepatology and The FASEB Journal.

In The Last Decade

Yu Seol Lee

14 papers receiving 454 citations

Peers

Countries citing papers authored by Yu Seol Lee

Since Specialization

Citations

This map shows the geographic impact of Yu Seol Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Seol Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Seol Lee more than expected).

Fields of papers citing papers by Yu Seol Lee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu Seol Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Seol Lee. The network helps show where Yu Seol Lee may publish in the future.

Co-authorship network of co-authors of Yu Seol Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Yu Seol Lee. A scholar is included among the top collaborators of Yu Seol Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu Seol Lee. Yu Seol Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	Repositioning of ezetimibe for the treatment of idiopathic pulmonary fibrosis 2024 ·European Respiratory Journal ·Chan Ho Lee, (unknown), Jisu Han, Ju Hye Shin, (unknown), Yu Seol Lee, Jeong Su Park, Beom Jin Lim, Jin Gu Lee, Young Sam Kim, Song Yee Kim, Soo Han Bae	5
2	Fecal microbiota transplantation improves hepatic fibro-inflammation via regulating oxidative stress in experimental NASH 2023 ·Digestive and Liver Disease ·Da Hyun Lee, (unknown), Yu Seol Lee, (unknown), (unknown), Hye Won Lee, Hong Koh, Soo Han Bae	11
3	Lysosomal Ca2+-mediated TFEB activation modulates mitophagy and functional adaptation of pancreatic β-cells to metabolic stress 2022 ·Nature Communications ·Kihyoun Park, H.J. Lim, Jinyoung Kim, (unknown), Yu Seol Lee, Soo Han Bae, Hyeongseok Kim, Hail Kim, Shin‐Wook Kang, Joo Young Kim, Myung‐Shik Lee	45
4	PERK prevents hepatic lipotoxicity by activating the p62-ULK1 axis-mediated noncanonical KEAP1-Nrf2 pathway 2022 ·Redox Biology ·Da Hyun Lee, Jeong Su Park, Yu Seol Lee, Soo Han Bae	29
5	Co-administration of ursodeoxycholic acid with rosuvastatin/ezetimibe in a non-alcoholic fatty liver disease model 2022 ·Gastroenterology report ·Sang Hyun Seo, Da Hyun Lee, Yu Seol Lee, Kyung Joo Cho, Hye Jung Park, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Soo Han Bae, Seung Up Kim	8
6	A GLP‐1/GLP‐2 receptor dual agonist to treat NASH: Targeting the gut‐liver axis and microbiome 2021 ·Hepatology ·Eun Ran Kim, Jeong Su Park, Jin Hee Kim, Ji Young Oh, (unknown), (unknown), Yu Seol Lee, (unknown), (unknown), (unknown), Da Hyun Lee, Jae Hee Cheon, Jin‐Woo Bae, Minyoung Lee, Jin Won Cho, (unknown), (unknown), (unknown), Myung‐Shik Lee, Soo Han Bae, Yong‐ho Lee	55
7	SQSTM1/p62 activates NFE2L2/NRF2 via ULK1-mediated autophagic KEAP1 degradation and protects mouse liver from lipotoxicity 2020 ·Autophagy ·Da Hyun Lee, Jeong Su Park, Yu Seol Lee, (unknown), Dong‐Kyu Lee, Sung Won Kwon, Dai Hoon Han, Yong‐ho Lee, Soo Han Bae	166
8	Repositioning of niclosamide ethanolamine (NEN), an anthelmintic drug, for the treatment of lipotoxicity 2019 ·Free Radical Biology and Medicine ·Jeong Su Park, Yu Seol Lee, Da Hyun Lee, Soo Han Bae	17
9	Inactivation of Sirtuin2 protects mice from acetaminophen-induced liver injury: possible involvement of ER stress and S6K1 activation 2019 ·BMB Reports ·Da Hyun Lee, Buhyun Lee, Jeong Su Park, Yu Seol Lee, Jin Hee Kim, Yejin Cho, (unknown), Hyunseok Kim, Yong‐ho Lee, Ki Taek Nam, Soo Han Bae	16
10	Ezetimibe ameliorates lipid accumulation during adipogenesis by regulating the AMPK–mTORC1 pathway 2019 ·The FASEB Journal ·Yu Seol Lee, Jeong Su Park, Da Hyun Lee, (unknown), Soo Han Bae	13
11	Dual roles of ULK1 (unc-51 like autophagy activating kinase 1) in cytoprotection against lipotoxicity 2019 ·Autophagy ·Jeong Su Park, Da Hyun Lee, Yu Seol Lee, (unknown), Kwang‐Hee Bae, Kyoung‐Jin Oh, Hyun-Mi Kim, Soo Han Bae	35
12	The Antidiabetic Drug Lobeglitazone Protects Mice From Lipogenesis-Induced Liver Injury via Mechanistic Target of Rapamycin Complex 1 Inhibition 2018 ·Frontiers in Endocrinology ·Yu Seol Lee, Jeong Su Park, Da Hyun Lee, Dong‐Kyu Lee, Sung Won Kwon, Byung‐Wan Lee, Soo Han Bae	8
13	The hypertension drug, verapamil, activates Nrf2 by promoting p62-dependent autophagic Keap1 degradation and prevents acetaminophen-induced cytotoxicity 2017 ·BMB Reports ·Da Hyun Lee, Jeong Su Park, Yu Seol Lee, Su Haeng Sung, Yong‐ho Lee, Soo Han Bae	30
14	p62/SQSTM1 is required for the protection against endoplasmic reticulum stress-induced apoptotic cell death 2016 ·Free Radical Research ·Jeong Su Park, Sue Young Oh, Da Hyun Lee, Yu Seol Lee, Su Haeng Sung, (unknown), Moon Joo Lee, Yong‐ho Lee, Sue Goo Rhee, Soo Han Bae	21

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact